Eurofins Genomics US is proud to announce the opening of a new world-class oligonucleotide manufacturing facility. The expansion significantly increases manufacturing capacity and capabilities, allowing Eurofins Genomics US to meet the ever-growing global demand for GMP-grade and research use oligonucleotides.